Search Results

Recently, a researcher at Children’s Hospital Los Angeles developed a new way to diagnose retinoblastoma by sampling the fluid at the front of the eye.

Children’s Hospital Los Angeles has appointed Lara Khouri, MBA, MPH, to be Executive Vice President and Chief Operating Officer.

EvoEndo®, Inc. is pleased to announce that Children’s Hospital Los Angeles is the first care center in California to use the EvoEndo® Single-Use Endoscopy System to perform a diagnostic unsedated TNE of the Upper Gastrointestinal Tract.

Senzime AB announced that it has secured a purchasing contract with the number one ranked children’s hospital system in the United States for its TetraGraph® quantitative neuromuscular monitoring system.

Children’s Hospital Los Angeles (CHLA) has launched the first clinical trial for Down syndrome regression disorder (DSRD), a rare and debilitating condition that affects adolescents and young adults with Down syndrome.

The Glioblastoma Foundation is proud to be a charity partner for the 2024 Los Angeles Marathon for the 5th year.

Researchers from Children’s Hospital of Philadelphia found that young children between the ages of 5 and 12 were more likely to experience a concussion from recreation and other non-sport activities, yet those injuries were not seen by specialists until days later compared with sports-related concussions in the same age group.